Home/Filings/4/0000899243-22-008062
4//SEC Filing

Kelly Timothy P 4

Accession 0000899243-22-008062

CIK 0001661998other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:05 PM ET

Size

7.9 KB

Accession

0000899243-22-008062

Insider Transaction Report

Form 4
Period: 2022-02-24
Kelly Timothy P
See Remarks
Transactions
  • Award

    Restricted Stock Units

    2022-02-24+4,8004,800 total
    Common Stock (4,800 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2022-02-24+28,20028,200 total
    Exercise: $2.71Exp: 2032-02-24Common Stock (28,200 underlying)
Footnotes (3)
  • [F1]The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
  • [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.

Issuer

Homology Medicines, Inc.

CIK 0001661998

Entity typeother

Related Parties

1
  • filerCIK 0001754067

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:05 PM ET
Size
7.9 KB